RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Amarogentin, a secoiridoid glycoside, activates AMP- activated protein kinase (AMPK) to exert beneficial vasculo-metabolic effects.

Amarogentin, a secoiridoid glycoside, activates AMP- activated protein kinase (AMPK) to exert beneficial vasculo-metabolic effects.

Add to Collection
2019 Aug Others UR Potunuru, KV Priya, MKNS Varsha, N Mehta… - … et Biophysica Acta (BBA …, 2019 - Elsevier

Full Author : ['Potunuru, Uma Rani', 'Priya, K Vishnu', 'Varsha, M K N Sai', 'Mehta, Nikunj', 'Chandel, Shivam', 'Manoj, Narayanan', 'Raman, Thiagarajan', 'Ramar, Manikandan', 'Gromiha, M Michael', 'Dixit, Madhulika']
Journal Title : Biochimica et biophysica acta. General subjects
Chapter : Section3
Journal Year : 2019
Cited by : 21.0

INTRODUCTION: AMP-activated protein kinase (AMPK) is a drug target for treatment of metabolic and cardiovascular complications. Extracts of Gentianaceace plants exhibit anti-diabetic and anti-atherosclerotic effects, however, whether their phyto-constitut..... Read More

Keywords : ["secoiridoid glycoside activate amp activate protein kinase ampk", "exert beneficial vasculometabolic effect", "amarogentin"]
PubMed Link : https://www.sciencedirect.com/science/article/pii/S0304416519301291
Google Scholar Link : https://scholar.google.com/scholar?cites=13802390077531771492&as_sdt=80005&sciodt=0,11&hl=en&num=20